Literature DB >> 1318806

Alpha-1 anti-trypsin and CD30 expression occur in parallel in activated T cells.

M S Bashir1, D B Jones, D H Wright.   

Abstract

We have performed an immunohistochemical study of immunoblastic T cell lymphoma and enteropathy-associated T cell lymphoma for alpha-1 anti-trypsin and CD30. Cytoplasmic staining for alpha 1 anti-trypsin is present in the malignant cells in both types of T cell neoplasm which also express CD30, a marker of lymphoid activation. Peripheral blood T lymphocytes on stimulation with mitogen also show granular cytoplasmic expression of alpha 1 anti-trypsin. Time course studies show that this parallels the expression of CD30. Alpha 1 anti-trypsin expression appears therefore to be associated with activation in T cells. Further studies of sub-fractionated T lymphocytes in vitro suggest that the expression of alpha 1 anti-trypsin on activation is not restricted to an individual lymphocyte subset.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1318806      PMCID: PMC1554524          DOI: 10.1111/j.1365-2249.1992.tb06484.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  30 in total

1.  Cirrhosis associated with alpha-1-antitrypsin deficiency: a previously unrecognized inherited disorder.

Authors:  H L Sharp; R A Bridges; W Krivit; E F Freier
Journal:  J Lab Clin Med       Date:  1969-06

2.  Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).

Authors:  J L Cordell; B Falini; W N Erber; A K Ghosh; Z Abdulaziz; S MacDonald; K A Pulford; H Stein; D Y Mason
Journal:  J Histochem Cytochem       Date:  1984-02       Impact factor: 2.479

3.  Synthesis of alpha 1-anti-trypsin by human monocytes.

Authors:  R van Furth; J A Kramps; M M Diesselhof-den Dulk
Journal:  Clin Exp Immunol       Date:  1983-03       Impact factor: 4.330

4.  The mechanism of cell-mediated cytotoxicity. I. Killing by murine cytotoxic T lymphocytes requires cell surface thiols and activated proteases.

Authors:  D Redelman; D Hudig
Journal:  J Immunol       Date:  1980-02       Impact factor: 5.422

5.  Liver in alpha1-antitrypsin deficiency: morphologic observations and in vitro synthesis of alpha1-antitrypsin.

Authors:  A K Bhan; R J Grand; H R Colten; C A Alper
Journal:  Pediatr Res       Date:  1976-01       Impact factor: 3.756

6.  Immunoregulation by alpha 1 antitrypsin.

Authors:  S N Breit; J P Robinson; E Luckhurst; P Clark; R Penny
Journal:  J Clin Lab Immunol       Date:  1982-02

7.  Plasminogen activator is an apparent lymphocyte mitogen.

Authors:  S D Cohen; E Israel; B Spiess-Meier; M A Wainberg
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

8.  Presence of alpha-1-antitrypsin on mitogen-stimulated human lymphocytes.

Authors:  J J Lipsky; R W Berninger; L R Hyman; R C Talamo
Journal:  J Immunol       Date:  1979-01       Impact factor: 5.422

Review 9.  The role of alpha 1-antitrypsin deficiency in the pathogenesis of immune disorders.

Authors:  S N Breit; D Wakefield; J P Robinson; E Luckhurst; P Clark; R Penny
Journal:  Clin Immunol Immunopathol       Date:  1985-06

10.  In vitro stimulation of lymphocytes by neutral proteinases from human polymorphonuclear leukocyte granules.

Authors:  T L Vischer; U Bretz; M Baggiolini
Journal:  J Exp Med       Date:  1976-10-01       Impact factor: 14.307

View more
  3 in total

1.  Alpha-1 antitrypsin gene exon use in stimulated lymphocytes.

Authors:  M S Bashir; K Morrison; D H Wright; D B Jones
Journal:  J Clin Pathol       Date:  1992-09       Impact factor: 3.411

2.  Constitutive overexpression of a novel 21 kDa protein by Hodgkin lymphoma and aggressive non-Hodgkin lymphomas.

Authors:  Minglong Zhou; Faisal M Fadlelmola; Jason B Cohn; Brian Skinnider; Randy D Gascoyne; Diponkar Banerjee
Journal:  Mol Cancer       Date:  2008-01-24       Impact factor: 27.401

3.  Alpha1-Antitrypsin in Urinary Extracellular Vesicles: A Potential Biomarker of Diabetic Kidney Disease Prior to Microalbuminuria.

Authors:  Jing Ning; Zhicong Xiang; Chongxiang Xiong; Qin Zhou; Xin Wang; Hequn Zou
Journal:  Diabetes Metab Syndr Obes       Date:  2020-06-17       Impact factor: 3.168

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.